Evan Friedman
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 7
-
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Marian Iwamoto (10 shared papers)John A. Wagner (8 shared papers)Eric H. Rubin (3 shared papers)Nancy Agrawal (2 shared papers)S. Aubrey Stoch (5 shared papers)Keith Gottesdiener (2 shared papers)Julie A. Stone (3 shared papers)Sheila Breidinger (3 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Clinical Cancer Research (2 papers)Cancer Research (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)IEEE Transactions on Neural Systems and Rehabilitation Engineering (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Evan Friedman
21 papers receiving 567 citations
Peers
Comparison fields: 5 of 69
- Virology 116
- Infectious Diseases 225
- Pharmacology 47
- Oncology 97
- Transplantation 8
Countries citing papers authored by Evan Friedman
This map shows the geographic impact of Evan Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Friedman more than expected).
Fields of papers citing papers by Evan Friedman
This network shows the impact of papers produced by Evan Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Friedman. The network helps show where Evan Friedman may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 98 | |
| 2 | 2020 | 68 | |
| 3 | 2008 | 59 | |
| 4 | 2013 | 58 | |
| 5 | 2010 | 46 | |
| 6 | 2009 | 42 | |
| 7 | 2009 | 40 | |
| 8 | 2009 | 37 | |
| 9 | 2021 | 32 | |
| 10 | 2011 | 30 | |
| 11 | 2016 | 22 | |
| 12 | 2019 | 22 | |
| 13 | 2024 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2014 | 5 | |
| 16 | Abstract #3604: A phase I single-rising dose study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of an oral akt inhibitor in healthy male volunteers | 2009 | 4 |
| 17 | 2020 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2016 | 2 | |
| 20 | 2024 | 2 |
About Evan Friedman
Evan Friedman is a scholar working on Infectious Diseases, Molecular Biology, Virology, Oncology and Pharmacology, having authored 22 papers that have together received 585 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Virology (116 citations), Infectious Diseases (225 citations), Pharmacology (47 citations), Oncology (97 citations) and Transplantation (8 citations). Evan Friedman has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Marian Iwamoto, John A. Wagner, Eric H. Rubin, Nancy Agrawal, S. Aubrey Stoch, Keith Gottesdiener, Julie A. Stone, Sheila Breidinger, Larissa Wenning and Punam Sandhu. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Cancer Research, Cancer Research, Antimicrobial Agents and Chemotherapy and IEEE Transactions on Neural Systems and Rehabilitation Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.